These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29540850)

  • 1. Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
    Kordelas L; da Silva Nardi F; Wagner B; Ditschkowski M; Liebregts T; Lindemann M; Heinemann FM; Horn PA; Beelen DW; Rebmann V
    Bone Marrow Transplant; 2018 Sep; 53(9):1149-1156. PubMed ID: 29540850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
    Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
    Front Immunol; 2019; 10():3027. PubMed ID: 31998310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
    Liu H; Chen Y; Xuan L; Wu X; Zhang Y; Fan Z; Huang F; Zhang X; Jiang Q; Sun J; Liu Q
    Acta Haematol; 2013; 130(3):160-8. PubMed ID: 23711991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells.
    Le Maux A; Noël G; Birebent B; Grosset JM; Vu N; De Guibert S; Bernard M; Semana G; Amiot L
    Clin Exp Immunol; 2008 Apr; 152(1):50-6. PubMed ID: 18241225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bu X; Zhong J; Li W; Cai S; Gao Y; Ping B
    Ann Hematol; 2021 Jun; 100(6):1391-1400. PubMed ID: 33709198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
    Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
    Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation.
    Waterhouse M; Duque-Afonso J; Wäsch R; Bertz H; Finke J
    Transplant Proc; 2013; 45(1):397-401. PubMed ID: 23267813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Wolf D; Wolf AM; Fong D; Rumpold H; Strasak A; Clausen J; Nachbaur D
    Transplantation; 2007 Apr; 83(8):1107-13. PubMed ID: 17452902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
    Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
    Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells.
    Siemaszko J; Łacina P; Szymczak D; Szeremet A; Majcherek M; Czyż A; Sobczyk-Kruszelnicka M; Fidyk W; Solarska I; Nasiłowska-Adamska B; Skowrońska P; Bieniaszewska M; Tomaszewska A; Basak GW; Giebel S; Wróbel T; Bogunia-Kubik K
    Front Immunol; 2023; 14():1227897. PubMed ID: 37901227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
    Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
    Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.